Latest Blogs

Don S. Dizon, MD, FACP, FASCO
May 05, 2021
Rare and Cured: A Conversation With Someone I Treated Years Ago
Many years ago I treated a patient with a rare sarcoma. We recently reconnected and she generously shared her experience of being treated for and now considered "cured" of her rare tumor, with a reminder that the cancer experience is unique to every individual.
Peter Paul Yu, MD, FASCO, FACP
May 04, 2021
The Prepared Mind: Looking to the Digital Future of Real-World Data
If luck, as Louis Pasteur noted, favors the prepared mind, how will oncologists not only prepare but extend cognitive capacity in an era where both medical knowledge and the scope of human endeavor that physicians must address continue to increase exponentially?
Guest Commentary
Apr 27, 2021
Should We Teach Cost-Effectiveness of Cancer-Related Therapies in Oncology Training?
With the current pace of progress in cancer care, urgent implementation of cost-effectiveness training curriculum in fellowship training programs will be indispensable, shares Dr. Samer Al Hadidi. 
International Perspectives
Apr 12, 2021
The Mentor Quest
"A successful mentorship is mutually beneficial for the mentor and mentee, where each party has to recognize and understand what the other is offering and whether it fits each career path," said Dr. Atlal Abusanad.
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the medical director for the Cancer Care Partnership with Penn State University Cancer Institute and professor of medicine at Penn State Hershey Cancer Institute. He has served as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is past president of the Pennsylvania Society of Oncology and Hematology. He serves as an ASCO delegate to the American Medical Association House of Delegates (AMA HOD).

Disclosure.

Nov 20, 2017
Aloha from the ASCO AMA House of Delegates
The ASCO delegation was very busy at the American Medical Association House of Delegates recent interim meeting.
Jun 29, 2017
AMA House of Delegates: These are Impactful Times
The most recent meeting of the AMA House of Delegates was a particularly important one for oncologists and cancer-related issues.
Nov 28, 2016
Become Engaged, Stay Engaged: More Important Than Ever
We (the ASCO delegation) have just returned from the interim American Medical Association (AMA) House of Delegates meeting in Orlando. ASCO proposed a resolution focused on the restrictive opioid policies being adopted by many states. Many of the state legislations include language restricting...
Jun 22, 2016
So Much Done, So Much More to Do: AMA House of Delegates Report
ASCO composed and successfully brought to the AMA-HOD several resolutions representing some of our most pressing concerns and/or initiatives, including regulations on handling hazardous materials, transparency on clinical pathways, reimbursement models, and Part B drug payments.
Jan 05, 2016
AMA House of Delegates: A Glimpse into the Future
ASCO staff and  member representatives gathered in Atlanta for the AMA House of Delegates' recent meeting, and, as usual, listened, learned, and spoke on a number of topics.
Jun 18, 2015
It’s Good to Grow—with the AMA-HOD
The AMA House of Delegates (AMA-HOD) convened a few days after the ASCO Annual Meeting.  It was, in many ways, a continuation of many of the concerns reviewed at the annual ASCO gathering. The delegation representing ASCO is now composed of ASCO staff, along with Drs. Thomas Marsland, Ray Page,...

Pages